Rm. Enrici et al., Long-term results of 60 patients with pathologic stage I & IIA Hodgkin's disease treated with exclusive mantle radiation therapy, EUR J HAEMA, 63(2), 1999, pp. 126-133
Between January 1972 and December 1982 60 patients with pathological stage
IA and IIA Hodgkin's disease (HD) were submitted to Mantle irradiation only
. Twenty-five were in stage I (32.1%) and 35 in stage II (67.9%). All patie
nts were submitted to staging laparotomy. Cases with large mediastinal mass
were excluded from this series. Delivered doses were 44 Gy in involved are
as, 40 Gy on the mediastinum and 36 Gy on uninvolved sites. Twenty-four pat
ients in stage I (96%) and 33 in stage II (94.2%) obtained complete remissi
on. Actuarial 10- and 20-yr overall (OS) rates were 86% and 79.1%, respecti
vely. Event-free (EFS) and relapse-free (RFS) survival rates at 10 and 20 y
r were 67.5% and 62.1%, respectively. The occurrence of disease relapse res
ulted in the only statistical significant prognostic factor for OS in both
univariate and multivariate analysis. Distant and extranodal recurrences we
re significantly (P<0.01) related to a reduced OS. On multivariate analysis
stage was the only determinant factor for increased RFS. Extended field RT
proved to be an effective curative modality for stage I HD patients, where
as 15 out of 33 patients in stage II relapsed requiring salvage therapy. Lo
ng-term analysis of survival and treatment-related morbidity rates will imp
rove our knowledge and assist the physicians to choose the therapeutic opti
on to offer to HD patients.